Oncology Pharmacy Think Tank: Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Adjuvant CDK4/6 Inhibitors in High-Risk HR+/HER2− EBC: Managing AEs and Administration Considerations to Optimize Adherence

Content Format:

Case Challenge

Credit Type:

ACPE-P

Credits:

0.25
Insight on Safety and Efficacy of ADCs in Solid Tumors: Focus on the Role of Oncology Pharmacists in Adverse Event Management

Content Format:

Text Module

Credit Type:

ACPE-P

Credits:

1.00
Insight on Safety and Efficacy of ADCs in Solid Tumors: Focus on the Role of Oncology Pharmacists in Adverse Event Management

Content Format:

Slideset

Credit Type:

--

Credits:

--
What Oncology Pharmacists Need to Know About ADCs in Solid Tumor Management

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
ADC AE Identification, Management, and Communication/Care Coordination

Content Format:

Slideset

Credit Type:

--

Credits:

--
How We Are Integrating New Findings Into Treatment for HER2-Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Express PointsSmarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CROI 2021: Highlights From Data on Emerging Treatment Options

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ART Safety and Tolerability: Questions, Answers, and More Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--